Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study

被引:54
作者
El-Khatib, Ziad [2 ,5 ]
Ekstrom, Anna Mia [2 ]
Coovadia, Ashraf [3 ,4 ]
Abrams, Elaine J. [6 ]
Petzold, Max [1 ]
Katzenstein, David [7 ]
Morris, Lynn [5 ]
Kuhn, Louise [8 ,9 ]
机构
[1] Nord Sch Publ Hlth NHV, Gothenburg, Sweden
[2] Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden
[3] Univ Witwatersrand, Rahima Moosa Mother & Child Hosp, Empilweni Serv, Fac Hlth Sci, Johannesburg, South Africa
[4] Univ Witwatersrand, Rahima Moosa Mother & Child Hosp, Res Unit, Fac Hlth Sci, Johannesburg, South Africa
[5] NICD, AIDS Virus Res Unit, Johannesburg, South Africa
[6] Columbia Univ, Int Ctr AIDS Programs, Mailman Sch Publ Hlth, New York, NY USA
[7] Stanford Univ, Div Infect Dis, Stanford, CA 94305 USA
[8] Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY USA
[9] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA
关键词
SINGLE-DOSE NEVIRAPINE; SUB-SAHARAN AFRICA; GREATER ADHERENCE; DRUG-RESISTANCE; VIRAL LOAD; ADULTS; HIV-1; TRANSMISSION; HIV/AIDS; CHILDREN;
D O I
10.1186/1471-2458-11-88
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Adherence is a necessary part of successful antiretroviral treatment (ART). We assessed risk factors for incomplete adherence among a cohort of HIV-infected women initiating ART and examined associations between adherence and virologic response to ART. Methods: A secondary data analysis was conducted on a cohort of 154 women initiating non-nucleoside reverse transcriptase inhibitor (NNRTI)-based ART at a single site in Johannesburg, South Africa. Ninety women had been enrolled in a prevention of mother-to-child transmission (pMTCT) program and were exposed to single-dose nevirapine (sdNVP) > 18 months earlier. Women were interviewed pre-treatment and clinical, virologic and adherence data were collected during follow-up to 24 weeks. Incomplete adherence to ART was defined as returning > 5% of medications, estimated by pill counts at scheduled visits. Multivariable logistic regression analysis and unadjusted odds ratio (95%CI) were performed, using STATA/SE (ver 10.1). Results: About half of the women (53%) were < 30 years of age, 63% had < 11 years of schooling, 69% were unemployed and 37% lived in a shack. Seven percent of women had a viral load > 400 copies/ml at 24 weeks and 37% had incomplete adherence at one or more visits. Incomplete adherence was associated with less education (p = 0.01) and lack of financial support from a partner (p = 0.02) after adjustment for confounders. Only when adherence levels dropped below 80% was there a significant association with viremia in the group overall (p = 0.02) although adherence < 95% was associated with viremia in the sdNVP-exposed group (p = 0.03). The main reasons for incomplete adherence were being away from home, busy with other things and forgetting to take their medication. Conclusion: Virologic response to NNRTI-treatment in the cohort was excellent. However, women who received sdNVP were at greater risk of virologic failure when adherence was < 95%. Women exposed to sdNVP, and those with less education and less social support may benefit from additional adherence counseling to ensure the long-term success of ART. More than 80% adherence may be sufficient to maintain virologic suppression on NNRTI-based regimens in the short-term, however complete adherence should be encouraged.
引用
收藏
页数:13
相关论文
共 54 条
[1]  
*ACTG OUTC COMM, 1999, ACTG QOL 601 602 QOL
[2]   Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia [J].
Amberbir, Alemayehu ;
Woldemichael, Kifle ;
Getachew, Sofonias ;
Girma, Belaineh ;
Deribe, Kebede .
BMC PUBLIC HEALTH, 2008, 8 (1)
[3]  
[Anonymous], 2006, UN ACC SCAL PRIOR HI
[4]  
[Anonymous], 2009, AIDS EP UPD
[5]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[6]   Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness [J].
Bangsberg, DR ;
Acosta, EP ;
Gupta, R ;
Guzman, D ;
Riley, ED ;
Harrigan, PR ;
Parkin, N ;
Deeks, SG .
AIDS, 2006, 20 (02) :223-231
[7]   Paradoxes of adherence and drug resistance to HIV antiretroviral therapy [J].
Bangsberg, DR ;
Moss, AR ;
Deeks, SG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :696-699
[8]   Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort Study [J].
Bing, EG ;
Hays, RD ;
Jacobson, LP ;
Chen, B ;
Gange, SJ ;
Kass, NE ;
Chmiel, JS ;
Zucconi, SL .
QUALITY OF LIFE RESEARCH, 2000, 9 (01) :55-63
[9]   Antiretroviral failure despite high levels of adherence: Discordant adherence-response relationship in Botswana [J].
Bisson, Gregory P. ;
Rowh, Adam ;
Weinstein, Rachel ;
Gaolathe, Tendani ;
Frank, Ian ;
Gross, Robert .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (01) :107-110
[10]   Peripartum nevirapine exposure and subsequent clinical outcomes among HIV-infected women receiving antiretroviral therapy for at least 12 months [J].
Chintu, Namwinga ;
Giganti, Mark J. ;
Putta, Nande B. ;
Sinkala, Moses ;
Sadoki, Ebedy ;
Stringer, Elizabeth M. ;
Stringer, Jeffrey S. A. ;
Chi, Benjamin H. .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (07) :842-847